Fintel reports that on November 20, 2025, JP Morgan initiated coverage of OPKO Health (NasdaqGS:OPK) with a Neutral recommendation. Analyst Price Forecast Suggests 185.76% Upside As of November 17, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Market forces rained on the parade of OPKO Health, Inc. (NASDAQ:OPK) shareholders today, when the analysts downgraded their forecasts for next year. Revenue and earnings per share (EPS) forecasts were ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare stocks. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare ...

Opko Health Inc. (NASDAQ:OPK) is one of the best strong buy penny stocks to buy now. On July 31, Opko Health Inc. (NASDAQ:OPK) reported its fiscal Q2 2025 results, with consolidated total revenues for ...

Good day. And welcome to the OPKO Health Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, ...

Good day, and welcome to the OPKO Health Third Quarter of 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, ...

Opko enters into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx). Opko says the purchase agreement is secured by its profit share payments from Pfizer received ...

Good afternoon, and welcome to the OPKO Health first quarter 2023 financial results conference call. [Operator instructions]. Please note, this event is being recorded. I would now like to turn the ...